J&J adds pain drug resources to responsible prescribing site
RARITAN, N.J. — Johnson & Johnson has launched several new tools on a website aimed at ensuring patients with pain get the drugs they need while staying safe.
J&J subsidiary Janssen Pharmaceuticals added resources and tools to PrescribeResponsibly.com for physicians and pharmacists to support appropriate and responsible treatment of pain. The site was originally launched early last year.
The new materials include pain and risk assessments to help doctors evaluate pain, manage harmful side effects and identify aberrant drug-related behavior, as well as general educational content written by experts.
"Millions of adult Americans suffer with acute or chronic pain," Vanderbilt University psychiatry and anesthesiology professor Steven Passik said. "Determining how to treat pain poses a challenge to both physicians and patients. It is important to ensure that issues often associated with opioid pain medicines — including abuse, addiction, misuse and diversion — do not prevent patients who need relief from having access to appropriate pain treatment."
Healthy Living Tour makes pit stop in Ga.
SAN FRANCISCO — The Health Mart Healthy Living Tour recently offered free health screenings at the 7th Annual 13th Congressional District Health Fair, hosted by Rep. David Scott, D-Ga., earlier this month.
Aboard the Health Mart Healthy Living Tour’s 40-ft. mobile screening unit, tour staff offered screenings that include blood pressure, cholesterol, blood glucose and hemoglobin A1C tests.
Co-sponsored by Bayer Diabetes Care and Novo Nordisk, the Healthy Living Tour continues through Nov. 4. The mobile screening unit is making 90 stops across 18 states this year.
Additionally, Health Mart is rewarding 10 Health Mart pharmacists across the country for going above and beyond the call of duty to provide exemplary education, guidance and service to people managing diabetes. Health Mart and co-sponsor Bayer Diabetes Care will hold small recognition ceremonies to honor select pharmacists, the company announced.
Sears Holdings reports sales decline, Kmart comps flat in Q2
HOFFMAN ESTATES, Ill. — Kmart comparable-store sales were flat, and Sears U.S. sales declined by 1.2% during second quarter 2011, according to an earnings report released Thursday.
Kmart’s sales were $3.6 billion during the quarter, flat to second quarter 2010, while Sears Holdings as a whole had sales of $10.3 billion, down from $10.5 billion in second quarter 2010. The company had losses of $146 million, compared with $39 million in losses in second quarter 2010. Still, Kmart — which had 1,304 stores as of July 30 — experienced increases in sales in several categories, including pharmacy and drugs.
"We are not satisfied with our results and are taking actions to turn around our performance in a challenging economic environment," Sears Holdings president and CEO Lou D’Ambrosio said. "While we improved our revenue trend, including growing our online business by over 30%, we had lower gross margins."